Mazdutide Research Phase Mazdutide (IBI362) Category Weight Loss & Metabolism AliasesIBI362 AdministrationSubcutaneous injection OverviewHow it worksTimingBenefitsSide effectsResearchSources Research and regulatory 📋 Development stage Approved in China for weight management as of 2026; in ongoing trials elsewhere; not FDA approved in the United States. ⚖️ Legal and regulatory Approved in China; investigational and not FDA approved in the United States. ⚠️ Side effects GI symptoms (most common), nausea